![](/events_files/1164/24CONF-ECA 2025-Banner-hero2.jpg?1725173874)
The 4th International Electronic Conference on Antibiotics
Challenges and Strategies for the Antibiotic Resistance Crisis
Part of the International Electronic Conference on Antibiotics series
21–23 May 2025
![](/images/event-public/calendar_white.png?version=0ca6df2307351cd993fe5c7896f0ceae)
![](/images/event-public/calendar_white.png?version=0ca6df2307351cd993fe5c7896f0ceae)
![](/images/event-public/calendar_white.png?version=0ca6df2307351cd993fe5c7896f0ceae)
Antibiotics Stewardship, Antimicrobial Use, Antibiotics Resistance, Novel Antimicrobial Agents, Multidisciplinary Antimicrobial Strategies, Antibiotic Clinical Studies, Artificial Intelligence Strategies
- Go to the Sessions
-
- S1. Antibiotics Stewardship and Antimicrobial Use in Healthcare Settings
- S2. Antibiotics and One Health
- S3. Epidemiology, Prevalence and Mechanisms of Antibiotic Resistance and Cross-Resistance
- S4. Novel Antimicrobial Agents: Discovery, Design, Synthesis and Action
- S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
- S6. Antibiotic Clinical Studies, Pharmacokinetics and Pharmacodynamics
- S7. Clinical and Environmental Impact of Bacterial Biofilms
- S8. Artificial Intelligence Strategies to Tackle Antibiotic Resistance
- Event Details
ECA 2025 will be FREE for Participation!
Join us today to register and submit your abstract, and be part of cutting-edge discussions and networking opportunities!
Welcome from the Chairs
We expect that participants of this conference will be able to exchange novel, provocative ideas by presenting short oral presentations on research and development and discoveries, as well as emphasizing challenges facing antibiotic resistance as a public health crisis.
Download the conference banner and share it with your colleagues!
Kind regards,
Prof. Dr. Manuel Simões,
Dr. Marc Maresca,
CNRS, Aix-Marseille University, Centrale Marseille, iSm2, Marseille, France
Chairs of the 4th International Electronic Conference on Antibiotics
Event Chairs
![](/events_files/1164/committee/2a1f271688d85358d7220264f6cbfc89.png?1725173874)
Department of Chemical Engineering, Faculty of Engineering, University of Porto, Portugal
keywords: antimicrobial agents; emerging antimicrobial strategies; antimicrobial resistance; biofilms; plant secondary metabolites
Manuel Simões has a PhD in Chemical and Biological Engineering and is currently Associate Professor with Habilitation at the Faculty of Engineering of the University of Porto, where he is Pro-Director. He has more than 180 papers published in journals indexed in JCR (h-index = 48), 4 books (1 as author and 3 as editor) and more than 40 chapters in books. His research focusses on biofilms and antimicrobial action and resistance. He has been highlighted as a highly cited author in 2020 and 2021 by Clarivate Analytics. SCOPUS ID: 55608338000; Orcid ID: 0000-0002-3355-4398.
![](/events_files/1164/committee/cc9d9f86433d19ca0a64418073eda0e5.jpeg?1725173874)
CNRS, Aix-Marseille University, Centrale Marseille, iSm2, Marseille, France
keywords: mycotoxins; fungal metabolites; antimicrobial; anticancer; antinflammatory; antioxidant
Dr. Marc Maresca is currently a researcher at Aix-Marseille Université. He received his Ph.D. in Biochemistry from the Université Paul Cézanne (France, 2003) working on food contaminants named mycotoxins. In 2003, he moved to England to work on enteropathogenic E coli in Brendan Keny’s lab. Then, he moved back to France to continue his work on mycotoxins and their effects on human health. He is currently working at Aix-Marseille Université and his research aims to identify and develop new molecules—natural, synthetic, or bio-inspired—with antimicrobial properties. He focuses on antimicrobial peptides and their mimics as well as on plant derivatives and evaluates, in addition to their antimicrobial effects, additional activities such as anti-inflammatory and anti-tumorigenic effects.
Event Committee
![](/events_files/1164/committee/ff33fa59c4c6154adf7f46e0167ea208.jpeg?1725173874)
Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Australia
Prof. Dr. Nick Dixon holds a PhD in Biochemistry from the University of Queensland (1978). He was a Research Fellow with Prof Alan Sargeson (Research School of Chemistry, ANU) before being awarded C.J. Martin and Fulbright Fellowships to study with Nobel laureate Prof Arthur Kornberg at Stanford University, U.S.A. He returned to the John Curtin School of Medical Research at ANU as a Queen Elizabeth II Fellow in 1983, and was appointed as Fellow in Biological Chemistry at the Research School of Chemistry, ANU in 1986. He was subsequently promoted to Senior Fellow and Professor, before leaving ANU in 2006 to take up his present position as Professor of Biological Chemistry at the University of Wollongong. He was awarded an Australian Research Council Australian Professorial Fellowship in 2008, and established UOW’s Centre for Medical and Molecular Bioscience in 2010. He is currently an academic leader of Molecular Horizons, a new facility for molecular visualization which opened in 2019.
![](/events_files/1164/committee/14515100b4400c529fe19c547e5ffc7a.jpeg?1725173874)
LMI CNRS UMR 5615, Université Lyon 1, Villeurbanne, France
Dr. Anthony W. Coleman studied at Huddersfield New College and qualified by competitive examination for admission to the University of Oxford. He was affiliated to Jesus College from 1972-76 obtaining an Honours degree in Chemistry. Publications 260 in Science Citation Index, 150 Invited and Plenary Talks and 22 Patents (3 licenced).
![](/events_files/1164/committee/debc36be8adc4ae158a2720b497ce903.jpeg?1725173874)
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He has headed several academic research teams (CNRS, INSERM and University), as well as a combined academic–industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins and microbes. He so far contributed to several books in toxicology and virology, and more than 180 scientific articles, 180 communications, and 55 patents in both biology and chemistry. He acts as the Editor-in-Chief of the journals Coronaviruses, Infectious Disorders – Drug Targets, and Venoms and Toxins. He is a member of 66 Editorial Boards of scientific journals, such as Peptides, Molecules, Antibiotics, Frontiers in Pharmacology, and the Journal of Biological Chemistry. He also reviewed articles submitted for publication in >100 international journals and acts as an expert for numerous national and international institutions. He won the ‘Citizen of the Year Award’ from The Nouvel Economiste (1994) for his work on antivirals. He is a member of a dozen scientific societies, such as the ‘American Peptide Society’ (charter member), ‘European Peptide Society’, ‘American Society for Microbiology’, ‘Biochemical Society’ and ‘New-York Academy of Sciences’.
![](/events_files/1164/committee/fb572a0fc68e9a45b9c846fc62d41a17.png?1725173874)
Department of Clinical Microbiology, Hospital Clinic, Barcelona, Spain
Dr. Vila is currently the Head of the Department of Clinical Microbiology of the Hospital Clinic in Barcelona, Full Professor of the School of Medicine, University of Barcelona, and Research Professor in the Institute for Global Health (ISGlobal) of Barcelona, Spain. His present main field of interest is in the investigation of the molecular bases of antimicrobial resistance and the development of new drugs against bacteria and molecular tools for rapid diagnosis of infectious diseases. Dr. Vila was the Programme Director of the Congress of the European Society of Clinical Microbiology (ESCMID) from 2009 to 2014 and he has been a member of the ICAAC Scientific Program Committee (USA) for 4 years. He received an Award of the National Plan against Antibiotic Resistance (PRAN) 2018 for the Micro-combat card game, presented by the Barcelona Global Health Institute Foundation (ISGlobal) in the category of better communication and public awareness initiative on the antibiotic resistance. He is also leading the Initiative of Antimicrobial Resistance in ISGlobal. He has published 476 articles in peer-reviewed journals, 44 book chapters and directed 25 doctoral theses (number of citations, 29.536 and H-index of 84, Google Scholar). He has patented three molecules.
![](/events_files/1164/committee/3f696cccad9c9650a6f57a40f1c0c8d7.jpeg?1725173874)
School of Food Science and Engineering, South China University of Technology, Guangzhou, China
Dr. Xu obtained a B.S. and Ph.D. from South China University of Technology in 2005 and 2011, respectively, and has worked as an Assistant Professor since 2011. Dr. Xu was awarded a Top 100 National Outstanding Doctoral Dissertation in 2014. His major research interests include microbial biofilm, antimicrobial resistance, polymicrobial interaction, and rapid detection. Dr. Xu is the co-founder and co-president of Asia-Pacific Biofilms (previously known as ChinaBiofilms). Dr. Xu has published more than 100 manuscripts as first or correspondence author, with the total IF > 260, citation > 5,000, H-Index as 42, and I-10 Index as 82. Professor, South China University of Technology, Guangzhou, China. Assistant Visiting Scientist, University of Maryland, College Park, United States. Distinguished Visiting Professor, Rajamangala University of Technology Phra Nakhon, Bangkok, Thailand. Adjunct Professor, National Institute of Fundamental Science, Kandy, Sri Lanka.
![](/events_files/1164/committee/f31a217f429d8dab1e612e306d93db12.jpeg?1725173874)
Department of Food Science and Nutrition, Faculty of the Environment, University of the Aegean, Greece
![](/events_files/1164/committee/91a5155280e9e8962c54a179d0264f2b.jpeg?1725173874)
Operations Manager, JMI Laboratories, A Subsidiary of Element Materials Technology, North Liberty, USA
Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of
Lille, Lille, France
Sessions
S2. Antibiotics and One Health
S3. Epidemiology, Prevalence and Mechanisms of Antibiotic Resistance and Cross-Resistance
S4. Novel Antimicrobial Agents: Discovery, Design, Synthesis and Action
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
S6. Antibiotic Clinical Studies, Pharmacokinetics and Pharmacodynamics
S7. Clinical and Environmental Impact of Bacterial Biofilms
S8. Artificial Intelligence Strategies to Tackle Antibiotic Resistance
Registration
The registration for ECA2025 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 16th May 2025 .
Instructions for Authors
ECA2025 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.
2. File format: PDF (.pdf).
3. Size in pixel: 1,080 width x 1,536 height–portrait orientation.
4. Size in cm: 38.1 width x 54.2 height–portrait orientation.
5. Font size: ≥16.
You can use our free template to create your poster. The poster template can be downloaded here.
Poster Gallery
Authors who wish to present a poster are invited to send it to the conference email at eca2025@mdpi.com. All posters will be permanently exhibited online in the Poster Gallery.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
Proceeding Paper Publication
Full author names
Affiliations (including full postal address) and authors' e-mail addresses
Abstract
Keywords
Introduction
Methods
Results and Discussion
Conclusions
Acknowledgements
References
Event Awards
![](/events_files/1164/customs/25d864caef7ea2a2a640acaea2b65413.png)
The Awards
Number of Awards Available: 5
The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be five winners selected for these awards. Best Oral Presentation Award will receive a certificate and 300 CHF and Best Poster Award will receive a certificate and 200 CHF.
Conference Secretariat
Ms. Ariel Zhang
Ms. Cheryl Han
Email: eca2025@mdpi.com